Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
255% for me as of today. Hat tip to this board for the heads up... my first options trade. Still holding though.
To hold or not to hold through earnings.
Public Workshop - Robotically-Assisted Surgical Devices: Challenges and Opportunities, July 27-28, 2015
FYI in case any of you want to attend / provide input for FDA guidance.
There is also a great PDF that touches on the current landscape, history of robotics, etc.
http://www.fda.gov/downloads/MedicalDevices/NewsEvents/WorkshopsConferences/UCM454811.pdf
There's no question there has been talks between Titan and a potential acquirer. At this point in the game, a potential acquirer is often invested in the company or providing strategic insight and guiding them to a position that would make it feasible for the company to purchase the technology. Due Diligence and conversations happen continuously by major players around these types of companies.
I believe that if they are to get acquired, it will likely occur post-CE mark and pre-FDA approval, but will hinge around the DD talks occurring over time. Even if funding stops shorts, all it takes is a small bridge loan from this player to put down and then acquire the company once it meets the respective milestone.
Funny - I've heard the same exact thing from my Porsche enthusiast neighbor. He swears by his Golf R among his super cars and he's owned pretty much every option out there.
I'd love to get some seat time in the new 911 Turbo or GT3. I often drive a 997 GT3RS and it's a fun car - a lot less scary than the 996 GT2 owned prior.
That's great - E46 M3's are a fun car on the track, but as you said... jack of all trades master of none. I own an e92 but it has not seen track time. My uncle tracks his Z06 (mostly stock) and smokes everyone in his class, it's a beast on the track.
Awesome! Would love to do European Delivery one day. BMW man myself - M3 and 1-Series currently.
Thanks, JUrology! Appreciate the recap.
$68/min in OR - Obviously varying per procedure, but is this close to half the current costs?!
I agree - buffer is back loaded.
Didn't realize he was in the industry as well, and local at that.
Absolutely we have. Titan likely is and has been in talks with some major players in the med device industry. These companies aren't going to move forward with a deal unless it makes sense on their end. This typically comes down to the risk level of the acquisition. Titan needs to independently de-risk, but will stay in contact with these potential acquirers throughout the process as they offer feedback. Chances are we'll see an acquisition right around CE Mark.
Here we go boys.
Agreed - I wouldn't be too worried at this point. Bertner has been around the block and so has the team behind Titan. They have a solid plan and with my prediction will come out ahead of the timeline for sure. No doubt there will be success in the future, but this will slowly climb through 2015 and we'll see it pop on a day we're least expecting.
A lot of my colleague have led startup companies in the medical device industry and I have followed many outside of this group. This is an easy criteria applied to any concept and if all points are hit it's usually a success:
- Is it good for the patient?
- Is it good for the customer/Physician?
- Is it good for the payor (insurance/medicare)?
- Is there a need for the product?
- Is the team behind the product a good team (Most important)
Titan hits all of these and I'm looking forward to success in the company and for all of you.
Thanks for the heads up! Reading...
Been picking up shares throughout the past week and had an order on the open this morning. Most of my cost basis is in the $2s so now is a great range to buy for me as I'm long.
Company giving the primary investigator shares sounds like a conflict of interest.
That I am not sure off. I'll have to call and ask this week. I would think since the shares are being issued by Titan Medical that they would be issued as TMD on the Canadian Exchange. But I am not sure. Please post up any warrant information you come across.
I would like the option to exercise to get shares, but it may be a big hassle being in the U.S. unless there is an easy way to remove the U.S. Legend that someone may know of. Otherwise I would just trade the warrants without exercising.
Warrant Update for Schwab and Fidelity.
Schwab remains the same as I previously posted. International trading for the warrant symbols will need to be added to your account and enabled on the back end. Warrants can be bought and sold but you must call and place the orders through a representative. Warrants can be exercised to receive shares, but they will hold the U.S. Restriction. Schwab is unable to remove this and doesn't have any further information regarding that restriction.
Received updated info from Fidelity. Very similar to Schwab as you must have international trading enabled on your end and the broker's end to trade these symbols. However, warrants can be bought/sold electronically and does not require verbal trade. Exercising warrants to purchase shares will need to be done verbally with a representative. Respective shares will hold the U.S. Restriction and there is no further information on removing this restriction. Fidelity recommended contacting the issuing company regarding restriction.
In my case Fidelity trade costs were ~30% cheaper than Schwab. Of course this can vary person-to-person. Having the ability to trade electronically is also a benefit of Fidelity of Schwab.
Both companies still do not have a solid answer regarding U.S. Restriction. This definitely concerns me as I'd like to have the option to exercise the warrants and be able to freely trade the shares. Does anyone have further info around this?
FYI on my experience... Schwab will allow you to buy warrants, but cannot send certificate of warrants to user. Also if exercised, shares will hold the U.S Restriction and Schwab cannot remove. Warrants can still be traded though.
Waiting to hear back from Fidelity.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=112915759
This is huge and only just the beginning. Love this progress.
Absolutely - I know more people in the industry under NDAs for Titan competitors than I do for Titan (which is zero). This is several people for competing companies, not just 1 vs. 0. Hence my investment across the field and not just Titan.
Agree with all sentiments. Titan is only on the map of investors in the company, users of intuitive systems, physicians/medical staff involved with MIS, and others in the medical industry that understand the potential; of course a few outliers there as well.
Most biotech/pharma/medical device companies don't even get put on the map until they're traded on a mainstream exchange and when there is less risk or even right before/after the announcement of an FDA milestone.
Although the company does have a fiscal responsibility to their shareholders, I do prefer and understand that they have their heads down doing the work, checking off milestones, and getting this device to market. That is why I am long and am in early (as most of us) despite the risk.
Lots of unknowns speaking with my brokerages around this (Schwab & Fidelity).
Schwab can allow trading of warrants and exercising the warrants. They also said they cannot send the warrant certificate to the user. However if the user does exercise the warrants, they stated they will be unable to remove the U.S. Legend which would not allow a user to trade the shares and is therefore pointless to exercise. Will need to follow up with Olympia to see if they play any part in this.
Waiting for more information from Fidelity to see if they can issue the warrant certifications and remove the U.S. legend, they had no idea as of now.
Got it. Thanks for all the help. Have been talking with my brokerage (Schwab) and they will allow me to purchase warrants however they said if I exercise them I will receive restricted stock units with no time-frame on the restriction and will not be able to sell them. I could sell the warrants though. Found some previous posts on this, but did not see a definite answer.
Is there a way around this?
Awesome! Great to hear they are on track for 510(k) submission as well. Good news all around.
At the exercise price or the PPS at the time of buyout?
In the event of a buyout that occurs before the expiration date on some warrants, what happens to those warrants?
FYI - TransEnterix, Inc. announced today that Todd M. Pope, President and Chief Executive Officer, will host an Analyst Event featuring an expert panel of laparoscopic surgeons. The surgeon panel will speak about their evaluations of the TransEnterix SurgiBotâ„¢ System, a minimally invasive surgical robotic system that allows the surgeon to be patient-side within the sterile field, currently in development.
The event is scheduled to take place at 10:00am CT / 11:00am ET on Friday, April 17, 2015 at the Gaylord Opryland Resort and Convention Center in Nashville, TN, and can be heard through live audio webcast.
To access the live audio webcast or archived recording, use the following link http://ir.transenterix.com/events.cfm. The replay will be available on the company’s website.
http://www.businesswire.com/news/home/20150408005604/en/TransEnterix-Host-Analyst-Event#.VSalTfnF8-I
I'm not for posting about other companies on this board, but I'm all for gaining competitive intelligence. Looks like there will be some general laparoscopic discussions as well. I'm invested in both companies and see them both succeeding.
TransEnterix, Inc. announced today that Todd M. Pope, President and Chief Executive Officer, will host an Analyst Event featuring an expert panel of laparoscopic surgeons. The surgeon panel will speak about their evaluations of the TransEnterix SurgiBotâ„¢ System, a minimally invasive surgical robotic system that allows the surgeon to be patient-side within the sterile field, currently in development.
The event is scheduled to take place at 10:00am CT / 11:00am ET on Friday, April 17, 2015 at the Gaylord Opryland Resort and Convention Center in Nashville, TN, and can be heard through live audio webcast.
To access the live audio webcast or archived recording, use the following link http://ir.transenterix.com/events.cfm. The replay will be available on the company’s website.
http://www.businesswire.com/news/home/20150408005604/en/TransEnterix-Host-Analyst-Event#.VSalTfnF8-I
Looking forward to it. Great support at these levels.
Are warrants still available to be bought at this time? How would they be bought in the US? I remember there was a lot of talk about this months ago if someone could link me to some valuable posts. Granted if my first question is negative, this discussion is nil.
Surgeon Uses da Vinci Robot to Craft the Perfect Ham and Cheese Sandwich
http://www.gomerblog.com/2015/03/da-vinci-robot/
haha.
Slightly disappointing. Hopefully we see a gradual climb back up to around $2. PPS still is undervalued in my opinion. This milestone puts us right back on track, though the long-term plan has been extended which will eat into the price a little.
A lot of M&A activity is being shifted to later-stage companies (FDA) and inclusive of CE market. Small amount is occurring for developmental stage companies. Check out this market report by SVB if you haven't already: http://bit.ly/1ydUvMG
Titan is making its way through the toughest milestones. From here on out it is smooth sailing provided they keep their heads on straight and working hard.
This isn't to say that larger sponsors have not been in discussion with TITXF. It's fairly common for a large player to be in contact with smaller device companies as they go through development. Several have probably talked to Titan, but the timing is not right and it's a "let's talk when you are X". Earliest Titan would get acquired, IMO, is after CE mark. I'm sure at this time several players will biting at an acquisition and the price will be driven up.
It's definitely big, but not surprising. We all figured they were on track and were poised to beat expectations of their "new" milestone schedule. Glad to see this is how it's unfolding. Still looks like it's going to be a slow year. But hopefully with some solid updates through the months we'll hold steady and continue growing.
Great write up! You hit on all the pressure points. Enjoyed reading it... hopefully other investors can read further into TRXC with these articles and see the opportunity.
Glad you called out the investments behind TRXC. It's important to realize who is invested in this company as it further speaks to the planned success of the product and team.
You mentioned there's a lot of market opportunity for new players. This goes for TRXC and its competitors that are coming to market. I look forward to profiting from all of them.
Awesome news! Love it! Long and strong.
Buy on tomorrow or buy today for tomorrow? ;)
Looking into ECIG...
Great results! Thanks for sending this link I hadn't read that article yet. Echos the other earnings reports that were posted earlier though. Good quarter for TRXC and on track.
There are arguments for both robotics in the sterile field and outside of the sterile field. Both companies are different market segments and will be successful.